Wilmé Valérie, Harscoat Sébastien, Séverac François, Carmona Adrien, Le Borgne Pierrick, Bilbault Pascal, Morel Olivier, Kepka Sabrina
Emergency Department, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg, France.
Public Health Department, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg, France.
J Clin Med. 2023 May 14;12(10):3456. doi: 10.3390/jcm12103456.
Non-ST elevation acute coronary syndrome (NSTE-ACS) is one of the most frequent manifestations of coronary artery disease. The occurrence of serious heart rhythm disorders (SHRDs) in NSTE-ACS is not well documented. However, continuous heart rhythm monitoring is recommended during the initial management of NSTE-ACS. The targeted monitoring of patients at greater risk for SHRDs could facilitate patients' care in emergency departments (EDs) where the flow of patients is continuously increasing.
This retrospective single-center study included 480 patients from emergency and cardiology departments within the Strasbourg University Hospital between 1 January 2019 and 31 December 2020. The objective was to estimate the frequency of the occurrence of SHRDs among patients with NSTE-ACS. The secondary objective was to highlight the factors associated with a higher risk of SHRDs.
The proportion of SHRDs during the first 48 h of hospital care was 2.3% (CI95%: 1.2-4.1%, n = 11). Two time periods were considered: before coronary angiography (1.0%), and during, or after coronary angiography (1.3%). In the first group, two patients required immediate treatment (0.4% of the patients) and no death occurred. In the univariate analysis, the variables significantly associated with SHRDs were age, anticoagulant medication, a decrease in glomerular filtration rate, plasmatic hemoglobin, and left ventricle ejection fraction (LVEF), and an increase in plasmatic troponin, BNP, and CRP levels. In the multivariable analysis, plasmatic hemoglobin > 12 g/dL seemed to be a protective factor for SHRDs.
In this study, SHRDs were rare and, most often, spontaneously resolved. These data challenge the relevance of systematic rhythm monitoring during the initial management of patients with NSTE-ACS.
非ST段抬高型急性冠状动脉综合征(NSTE-ACS)是冠状动脉疾病最常见的表现之一。NSTE-ACS中严重心律失常(SHRDs)的发生情况尚无充分记录。然而,在NSTE-ACS的初始治疗期间建议进行持续的心律监测。对SHRDs风险较高的患者进行有针对性的监测,有助于在患者流量不断增加的急诊科(EDs)对患者进行护理。
这项回顾性单中心研究纳入了2019年1月1日至2020年12月31日期间斯特拉斯堡大学医院急诊科和心内科的480例患者。目的是估计NSTE-ACS患者中SHRDs的发生频率。次要目的是突出与SHRDs较高风险相关的因素。
住院治疗的前48小时内SHRDs的比例为2.3%(95%CI:1.2-4.1%,n = 11)。考虑了两个时间段:冠状动脉造影前(1.0%),以及冠状动脉造影期间或之后(1.3%)。在第一组中,两名患者需要立即治疗(占患者的0.4%),且无死亡发生。在单变量分析中,与SHRDs显著相关的变量有年龄(抗凝药物、肾小球滤过率降低、血浆血红蛋白、左心室射血分数(LVEF),以及血浆肌钙蛋白、脑钠肽(BNP)和C反应蛋白(CRP)水平升高。在多变量分析中,血浆血红蛋白>12 g/dL似乎是SHRDs的一个保护因素。
在本研究中,SHRDs很少见,且大多能自发缓解。这些数据对NSTE-ACS患者初始治疗期间系统心律监测的相关性提出了质疑。